P&G beauty sales surge on 'superiority' push as Q3 2021 sales continue to rise

By Kacey Culliney

- Last updated on GMT

Procter & Gamble reported especially strong sales in its premium beauty business - results that align with the company's superiority strategy (Getty Images)
Procter & Gamble reported especially strong sales in its premium beauty business - results that align with the company's superiority strategy (Getty Images)

Related tags Procter & gamble P&g financial results Prestige beauty COVID-19 premium beauty

Personal care giant Procter & Gamble (P&G) has reported a net sales rise for its third quarter (Q3) of fiscal 2021, with beauty leading the charge in growth terms.

P&G tallied up net sales of €15bn ($18.1bn) for Q3 of fiscal 2021, up 5% on the previous year. Total net earnings were up 12% for the quarter at €2.7bn ($3.2bn).

Sales growth was led by a 9% net sales surge in beauty; 8% in fabric and home care; and 4% in both grooming and health care. Baby, feminine and family care remained flat for the quarter. Globally, European focused markets were down.

David Taylor, chairman, president and CEO of P&G, said the results were “solid”​ across the board in what continued to be a “challenging operating environment”.

“We remain focused on executing our strategies of superiority, productivity, constructive disruption and improving P&G’s organisation and culture. These strategies enabled us to build strong business momentum before the COVID crisis and accelerate our progress during the crisis, and they remain the right strategies to deliver balanced growth and value creation over the long term,” ​Taylor said.

Beauty buoyed by premium innovation – SK-II especially strong

Within the beauty division, growth in the quarter had been driven by the super-premium SK-II brand – up more than 30% globally in the quarter – as well as other premium innovations in North America skin care and increased pricing. Hair care also reported an organic sales rise, largely led by innovations in China.

Speaking to investors on the Q3 2021 earnings call, Jon Moeller, vice chairman and COO of P&G, said: “We’ve focused our portfolio on daily use products in categories where performance plays a significant role in brand choice. In these performance-driven categories, we’ve raised the bar on all aspects of superiority, product package, brand communication, retail execution and value.”

Echoing sentiments from this year’s CAGNY 2021 conference​, Moeller said P&G continued to invest and back superiority: “Superior offerings delivered with superior execution drive market growth.”

And these investments were happening across all channels, including e-commerce, he said, with efforts being made in robust and protective packaging for home deliveries.

Post-COVID future? A ‘mindset of constructive disruption’

Discussing the future, Moeller said success required agility and that came with “the mindset of constructive disruption, a willingness to change, adapt and create new trends and technologies that will shape our industry for the future”.

“…Our business exhibited strong momentum (…) well before the COVID crisis. We’ve strengthened our position further during the crisis and we believe P&G is well-positioned to serve the heightened needs and new behaviours of consumers and our retail and distributor partners post-crisis,” ​he said.

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast